Why is There No AIDS Vaccine?

Pedro Rey-Biel

World Economics, 2001, vol. 2, issue 4, 117-132

Abstract: This paper provides an economic explanation for the non-existence of a vaccine against AIDS. It comments on previously claimed economic reasons why private laboratories do not have incentives to invest in an AIDS vaccine and provides a new one: private companies already operate in the market for treatment of already infected patients, which market is threatened by the eventual emergence of a vaccine that cuts the cycle of infection. Finally, the paper discusses some mechanisms to provide incentives for further private research in diseases where a treatment product already exists.

Date: 2001
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.worldeconomics.com/Journal/Papers/Article.details?ID=84 (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:wej:wldecn:84

Access Statistics for this article

More articles in World Economics from World Economics, 1 Ivory Square, Plantation Wharf, London, United Kingdom, SW11 3UE
Bibliographic data for series maintained by Ed Jones ().